DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Degasperi E, Spinetti A, Lombardi A. et al.
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure.
J Hepatol 2019;
71: 1106-1115
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.